Published in Thromb Haemost on November 23, 2010
Autologous bone marrow cell therapy for peripheral arterial disease. Stem Cells Cloning (2012) 0.85
The effect of iloprost on renal function in patients with critical limb ischemia. Curr Ther Res Clin Exp (2013) 0.75
Comparison of hyperbaric oxygen versus iloprost treatment in an experimental rat central retinal artery occlusion model. Graefes Arch Clin Exp Ophthalmol (2016) 0.75
The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation (2003) 2.14
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". J Am Coll Cardiol (2009) 2.11
Deep venous thrombosis and previous myocardial infarction in mild factor XII deficiency: a risk factor for both venous and arterial thrombosis. J Thromb Thrombolysis (2008) 1.96
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. Free Radic Biol Med (2007) 1.88
Soluble RAGE in type 2 diabetes: association with oxidative stress. Free Radic Biol Med (2007) 1.67
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. Stroke (2004) 1.57
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. JAMA (2004) 1.40
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol (2003) 1.39
Pentraxin 3 and Platelet Activation in Obese Patients After Gastric Banding. Circ J (2015) 1.39
Soluble forms of RAGE in internal medicine. Intern Emerg Med (2009) 1.28
Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women. J Clin Endocrinol Metab (2003) 1.22
Retracted Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. Arterioscler Thromb Vasc Biol (2004) 1.22
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. Curr Med Chem (2009) 1.18
Association between 5-lipoxygenase expression and plaque instability in humans. Arterioscler Thromb Vasc Biol (2005) 1.15
Soluble CD40 ligand plasma levels in lung cancer. Clin Cancer Res (2004) 1.15
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. Circulation (2002) 1.09
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. Arterioscler Thromb Vasc Biol (2005) 1.09
Diabetes mellitus and thrombosis. Thromb Res (2011) 1.04
Insulin resistance as a determinant of platelet activation in obese women. J Am Coll Cardiol (2006) 1.00
Inflammation, insulin resistance, and obesity. Curr Atheroscler Rep (2004) 0.98
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity. Circulation (2004) 0.97
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus. J Am Coll Cardiol (2005) 0.97
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. Circulation (2003) 0.96
Urinary excretion of lipoxin A(4) and related compounds: development of new extraction techniques for lipoxins. Lab Invest (2002) 0.94
Biomarkers of platelet activation in acute coronary syndromes. Thromb Haemost (2012) 0.94
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response. FASEB J (2010) 0.93
Prevention of edema, flight microangiopathy and venous thrombosis in long flights with elastic stockings. A randomized trial: The LONFLIT 4 Concorde Edema-SSL Study. Angiology (2002) 0.89
A novel flow cytometric approach to distinguish circulating endothelial cells from endothelial microparticles: relevance for the evaluation of endothelial dysfunction. J Immunol Methods (2012) 0.89
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels. Exp Gerontol (2005) 0.88
Platelet function in health and disease: from molecular mechanisms, redox considerations to novel therapeutic opportunities. Antioxid Redox Signal (2012) 0.88
Relative chemokine and adhesion molecule expression in Mediterranean spotted fever and African tick bite fever. J Infect (2008) 0.88
The LONFLIT4--Concorde Deep Venous Thrombosis and Edema Study: prevention with travel stockings. Angiology (2003) 0.88
CD40 ligand and MCP-1 as predictors of cardiovascular events in diabetic patients with stroke. J Atheroscler Thromb (2009) 0.86
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. Atherosclerosis (2010) 0.85
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. Blood (2008) 0.85
Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis. Stroke (2005) 0.84
Isoprostane formation and inhibition in atherothrombosis. Curr Opin Pharmacol (2005) 0.84
Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients. Free Radic Biol Med (2012) 0.83
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects. Diabetes Metab Res Rev (2008) 0.83
Determinants of platelet activation in Alzheimer's disease. Neurobiol Aging (2006) 0.83
Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype. J Am Heart Assoc (2013) 0.83
TP receptor activation and inhibition in atherothrombosis: the paradigm of diabetes mellitus. Intern Emerg Med (2010) 0.83
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. Thromb Haemost (2009) 0.82
Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria. Clin Sci (Lond) (2008) 0.82
Oxidant stress and platelet activation in hypercholesterolemia. Antioxid Redox Signal (2004) 0.82
Prediction of carotid plaques in hypertensive patients by risk factors, left ventricular hypertrophy, and epicardial adipose tissue thickness. Heart Vessels (2012) 0.81
Cholesterol-adjusted vitamin E serum levels are associated with cardiovascular events in patients with non-valvular atrial fibrillation. Int J Cardiol (2013) 0.81
Thromboxane receptors antagonists and/or synthase inhibitors. Handb Exp Pharmacol (2012) 0.81
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. Free Radic Biol Med (2010) 0.81
Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress. J Clin Endocrinol Metab (2012) 0.81
Oxidative Stress Modulation Through Habitual Physical Activity. Curr Pharm Des (2016) 0.81
Platelet function testing in contemporary clinical and interventional practice. Curr Treat Options Cardiovasc Med (2014) 0.80
Effects of high-amount-high-intensity exercise on in vivo platelet activation: modulation by lipid peroxidation and AGE/RAGE axis. Thromb Haemost (2013) 0.80
Stimulation of CCL2 (MCP-1) and CCL2 mRNA by substance P in LAD2 human mast cells. Transl Res (2009) 0.80
The use of commercially available personal UV-meters does cause less safe tanning habits: a randomized-controlled trial. Photochem Photobiol (2007) 0.79
Association between serum leptin levels and 24-hour blood pressure in obese women. Obes Res (2003) 0.79
Should patients with osteoarthritis be treated with COX2 inhibitors rather than traditional NSAIDs? Nat Clin Pract Rheumatol (2007) 0.78
Inhibitory activity of salicylic acid on lipoxygenase-dependent lipid peroxidation. Biochim Biophys Acta (2008) 0.78
Stress-induced salivary cortisol secretion during hypobaric hypoxia challenge and in vivo urinary thromboxane production in healthy male subjects. Stress (2011) 0.78
Determinants of platelet activation in hypertensives with microalbuminuria. Free Radic Biol Med (2009) 0.78
Cardiovascular risk and dietary sugar intake: is the link so sweet? Intern Emerg Med (2011) 0.78
Ankle-Brachial Index and cardiovascular events in atrial fibrillation. The ARAPACIS Study. Thromb Haemost (2016) 0.78
Bicarbonate-dependent, carbonate radical anion-driven tocopherol-mediated human LDL peroxidation: an in vitro and in vivo study. Free Radic Res (2012) 0.77
Soluble CD40 ligand and endothelial dysfunction in aspirin-treated polycythaemia vera patients. Br J Haematol (2009) 0.77
Inherited bleeding disorders: results from the Italian Regional Haemophilia Centre of Pescara. Blood Transfus (2008) 0.77
Low-density lipoprotein-lowering medication and platelet function. Pathophysiol Haemost Thromb (2006) 0.77
Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study. Intern Emerg Med (2014) 0.77